Cc1cc2c(c(C)c1Cl)C(c1ccc3c(c1)OCO3)CC(c1ccccc1)O2
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?